We are live on
!
Find out more
Puma Biotechnology
PBYI
PBYI
68 hedge funds and large institutions have $93.8M invested in Puma Biotechnology in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 14 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
512% more call options, than puts
Call options by funds: $1.41M | Put options by funds: $230K
9% more capital invested
Capital invested by funds: $86M → $93.8M (+$7.78M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2.69% less ownership
Funds ownership: 59.59% → 56.9% (-2.7%)
12% less funds holding
Funds holding: 77 → 68 (-9)
52% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 29
75% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 12
Holders
68
Holders Change
-9
Holders Change %
-11.69%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
14
Reduced
29
Closed
12
Calls
$1.41M
Puts
$230K
Net Calls
+$1.18M
Net Calls Change
+$281K
Top Buyers
Top Sellers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.13M |
| 2 |
EP
Eversept Partners
New York
|
-$873K |
| 3 |
Millennium Management
New York
|
-$560K |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$363K |
| 5 |
Two Sigma Investments
New York
|
-$318K |
